Response to Letter to the Editor From Kleebayoon and Wiuwanikit: “Subacute THYROiditis Related to SARS-CoV-2 Vaccine and COVID-19 (THYROVAC Study): A Multicenter Nationwide Study”
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad462 ↗Kurz gefasst
Kommentar in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Kemal Ağbaht und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Defne Hospital, Hatay 31080, Turkey. Hauptthemen laut MEDLINE: COVID-19, Thyroiditis, Subacute. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Defne Hospital, Hatay 31080, Turkey.
- Department of Endocrinology and Metabolism, Ankara University, School of Medicine, Ankara 06100, Turkey.
ORCID-Profile: Kemal Ağbaht, Mustafa Şahin
Zitieren
APA
Ağbaht, K., & Şahin, M. (2023). Response to Letter to the Editor From Kleebayoon and Wiuwanikit: “Subacute THYROiditis Related to SARS-CoV-2 Vaccine and COVID-19 (THYROVAC Study): A Multicenter Nationwide Study”. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad462
Vancouver
Ağbaht K, Şahin M. Response to Letter to the Editor From Kleebayoon and Wiuwanikit: “Subacute THYROiditis Related to SARS-CoV-2 Vaccine and COVID-19 (THYROVAC Study): A Multicenter Nationwide Study”. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad462
BibTeX
@article{Abaht2023,
author = {Ağbaht, Kemal and Şahin, Mustafa},
title = {Response to Letter to the Editor From Kleebayoon and Wiuwanikit: “Subacute THYROiditis Related to SARS-CoV-2 Vaccine and COVID-19 (THYROVAC Study): A Multicenter Nationwide Study”},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad462}
}
EUVIMED